Anna is a postdoctoral researcher in the Berlin Institute for Medical Systems Biology which forms part of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association. She is studying cell fate reprogramming using the model organism Caenorhabditis elegans.
